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ABSTRACT 
 
 
 
PURPOSE: The aim of the present study was to assess the test-retest and stability reliability of 
flow-mediated dilation (FMD) in the popliteal artery and to investigate the effect of occlusion 
pressure on the FMD response. METHODS: A series of FMD tests were performed on ten 
healthy young adult males to assess reliability. Ultrasound-derived artery diameter of the 
popliteal was measured and FMD was calculated as the percent change in diameter from 
baseline.  RESULTS: FMD measurements for intra- and interday comparisons demonstrated 
poor reliability (Repeatability 5.62 and 4.82%, Intraclass correlation coefficient [ICC] 0.36 and 
0.25, respectively).  Repeatability values were as large as the FMD measures themselves for both 
intra- and interday reliability.   CONCLUSION: Popliteal artery FMD has poor reliability for 
test-retest and stability reliability.  Interpretation of individual or group changes using this 
technique should be interpreted with caution.   
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1.1 Introduction 
When blood flow increases through a blood vessel, a resultant frictional force parallel to 
the vessel, termed shear stress, is applied.  An increase in shear stress on the vascular 
endothelium causes endothelium-dependent vasodilation (flow-mediated vasodilation [FMD]).  
In 1992, Celermajer et al. (Celermajer et al., 1992) developed a technique that took advantage of 
this physiological response and is currently a widely used, noninvasive technique to provide 
insight into vascular health.   
The reactive hyperemia endothelial function test, commonly referred to as an FMD test, 
uses ultrasound assessment of FMD in response to cuff release following an occlusion period.  
This technique generates a shear stress stimulus, resulting in a dilation of downstream resistance 
vessels following the occlusion of blood flow to the limb with a pressure cuff.  Upon release of 
the occlusion, inflow through the conduit artery is transiently increased (reactive hyperemia) and 
acts as the stimulus for FMD.   
In humans FMD is typically assessed in the large peripheral conduit arteries and is 
considered representative of the response in more clinically relevant coronary circulation 
(Anderson et al., 1995; Takase et al., 1998).  As a result of the close relationship to the coronary 
circulation, the FMD test has become widely used as a measure of endothelial dysfunction in 
both clinical and asymptomatic patients.  Experimental and clinical studies suggest that 
endothelial dysfunction is an important feature of vascular disease and is strongly associated 
with several cardiovascular conditions, including atherosclerosis (Ross, 1999), hypertension 
(Taddei et al., 1993; Perticone et al., 2001; Modena et al., 2002), and coronary and peripheral 
artery disease (Yataco et al., 1999; Zhang et al., 2000; Neunteufl et al., 2000; Kuvin et al., 2001; 
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Brevetti et al., 2003), and that endothelial dysfunction predicts cardiovascular events in these 
groups (Gokce et al., 2002; Widlansky et al., 2003). 
1.2 Physiology of FMD 
The endothelium is a single layer of cells lining all of the blood vessels in the body, also 
known as the tunica intima, and has been identified as playing a major role in smooth muscle 
dilation.  Animal studies established that FMD in arteries was dependent on the presence of an 
intact endothelial lining (Smiesko et al., 1985; Pohl et al., 1986).  Rubanyi et al. (Rubanyi et al., 
1986) indicated that, in response to shear stress, the endothelium released a substance that 
possessed the characteristics of Furchott’s endothelium-derived relaxing factor, now known as 
nitric oxide (NO) (Moncada et al., 1988).   
Reductions in FMD are widely assumed to reflect diminished NO production as several 
pivotal human studies have concluded that brachial and radial artery FMD are dependent on an 
NO pathway (Joannides et al., 1995; Mullen et al., 2001; Doshi et al., 2001; Jiang et al., 2011).  
Studies involving the administration of NO blockades, such as NG-monomethyl-L-arginine (L-
NMMA), have confirmed the major role that NO plays in vasoregulation.  Joannides et al. 
(Joannides et al., 1995) found that radial artery dilation following 3 minutes of ischemia was 
abolished in the presence of L-NMMA.  Similarly, Mullen et al. (Mullen et al., 2001) found that 
NO blockade decreased the radial artery FMD response to 5 minutes of ischemia from 5.3% to 
0.7% dilation, with no difference in hyperemic stimulus, concluding that it was unlikely that 
stimulus magnitude was responsible for the abolished FMD response. 
Figure 1 outlines the pathway of endothelial-dependent vasodilation in response to 
increases in fluid shear stress.  Although several vasodilators are released by the endothelium, 
the FMD test typically tries to isolate the NO pathway.  Following release of occlusion, during 
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an FMD test, the resultant increase in blood flow creates a shear stress stimulus causing 
deformation of mechanosensitive structures on the endothelial cell membrane, such as membrane 
proteins (glycocalyx), primary cilia and mechanosensitive ion channels (Pyke & Tschakovsky, 
2005; Davies, 2009).  The acute response to the shear stress stimulus is the opening of calcium 
(Ca++)-activated potassium channels, causing hyperpolarization of the endothelial cell (Olesen et 
al., 1988; Cooke et al., 1991; Miura et al., 2001).  This results in an increased driving force for 
Ca++ entry into the cell.  The Ca++ activates endothelial nitric oxide synthase (eNOS) which in 
turn increases the conversion of L-arginine to NO (Pohl et al., 1986; Joannides et al., 1995).  
Over prolonged periods of shear stress stimulus (minutes), the mechanosensitive structures signal 
increases G-protein expression and resultant phosphorylation of eNOS (Corson et al., 1996; 
Dimmeler et al., 1999).  The increase in eNOS activity increases the production of NO, even at 
low concentrations of calcium.    Vasodilators diffuse from the endothelial cell into the tunica 
media (composed of smooth muscle), trigger a signalling cascade which ultimately reduces 
intracellular [Ca++] and induces relaxation of the smooth muscle and subsequent vasodilation.   
As mentioned previously, there is some redundancy in the mechanisms controlling 
vasodilation.  In addition to multiple mechanosensitive structures on the endothelial cell surface, 
there are also multiple vasodilatory pathways within the endothelial cell which may facilitate 
FMD (Sun et al., 1999; Mullen et al., 2001; Doshi et al., 2001; Pyke et al., 2009; Parker et al., 
2011).  A study using blood vessels from mice genetically engineered to lack eNOS still 
responded to shear stress by dilating (Sun et al., 1999).  Other animal models have confirmed 
prostaglandins (PGs) and endothelial-derived hyperpolarizing factor (EDHF) also contribute to 
endothelium dependent vasorelaxation (Huang et al., 1998; Pak et al., 2002; Scotland et al., 
2005).  More recently Pyke et al. (Pyke et al., 2009) were unable to reduce radial artery FMD 
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with a large dose of L-NMMA and concluded that there may be heterogeneous vasodilator 
phenotypes which affect the contribution of NO to FMD.  
1.3 Methodological Considerations 
FMD has emerged as a popular technique in both clinical and physiological studies to 
examine the mechanisms that impact endothelial and vascular function.  It is clear, that minor 
changes in the methodological approach can significantly alter the nature and magnitude of the 
FMD response.  As a result of this, a series of reviews and tutorials have been published in an 
attempt to standardize the protocol of this widespread technique (Corretti et al., 2002; Pyke & 
Tschakovsky, 2005; Harris et al., 2010; Thijssen et al., 2011a).  Most recently, Thijssen et al. 
(Thijssen et al., 2011a) published methodological and physiological guidelines for several key 
aspects of the assessment of FMD in humans.  These guidelines included recommendations 
regarding subject preparation, test protocol, Doppler ultrasound technique and data analysis.   
FMD is typically assessed in peripheral conduit arteries, such as the brachial, radial and 
superficial femoral, although the popliteal artery has recently emerged as an alternative site for 
assessing endothelial function in the lower limbs.  During an FMD test, baseline ultrasound-
derived artery diameter and Doppler mean blood velocity (MBV) is established prior to the 
occlusion period.  Once baseline measures have been taken a pressure cuff is inflated to occlude 
blood flow to the forearm or lower leg, depending on the location of the FMD test.  Cuff position 
(distal or proximal to ultrasound measurements) has been shown to alter the FMD response by 
altering the contribution of vasoactive substances (Uehata et al., 1997; Mannion et al., 1998; 
Vogel et al., 2000).  Distal cuff occlusion on the brachial artery was associated with a 7% FMD, 
which was abolished by administration of NO blockade (Doshi et al., 2001).  Alternatively, 
proximal cuff occlusion was associated with a 12% brachial artery FMD that was only partially 
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reduced (to 7.5%) with the administration of an NO blockade.  These data suggest that cuff 
placement may affect the nature of the FMD response, by influencing the heterogeneity of 
vasodilatory pathways in the endothelium.  Distal cuff occlusion is considered to be greatly NO-
mediated, whereas additional factors are contributing to the dilation associated with proximal 
cuff placement.  Consequently, distal cuff placement is acknowledged as the standard practice to 
elicit an NO-dependent response.   
In addition to cuff position, occlusion duration can also affect the FMD response.  The 
change in brachial FMD increases as the duration of cuff inflation increases from 30 seconds to 5 
minutes (Corretti et al., 2002).  Although it has been suggested that there is no change in dilation 
following 5 or 10 minutes of occlusion (Corretti et al., 2002), this remains unclear.  Some studies 
have found that a 10 minute occlusion period results in a greater FMD response that is a result of 
contributions from non-NO, ischemic-induced vasodilators (Kooijman et al., 2008; Harris et al., 
2009).  As a result, a 5 minute occlusion period is the accepted duration to mediate an NO-
dependent FMD response. 
Following the 5 minutes of distal cuff occlusion, diameter and MBV are monitored for at 
least 3 minutes in upper limb arteries and 5 minutes in lower limb arteries.  Studies have found 
that peak diameters in the brachial artery, and similarly in the radial, typically occur within the 
first 120 seconds following release (Black et al., 2008; Irace et al., 2008; Padilla et al., 2009; 
Liuni et al., 2010).  Arteries in the legs demonstrate a significantly later peak than those in the 
arms (Thijssen et al., 2008).  Therefore, arteries such as the superficial femoral and popliteal 
should be monitored for 5 minutes following cuff release to ensure adequate detection of peak 
diameter. 
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1.4 Rationale 
The magnitude of FMD of the conduit arteries is a widely used test of endothelial 
function.  The FMD test has been documented to correlate with invasively assessed endothelial 
function in the coronary arteries (Anderson et al., 1995), and is now commonly used as an index 
of endothelial function and is often applied as a surrogate marker of cardiovascular disease 
(CVD).  As a diagnostic tool, it is important to understand the repeatability of this measure and 
the test-retest reliability, or the ability to reproduce similar results from consecutive tests within a 
single day.  It is critical to comprehend the limitations, if there are any, to taking a single 
measure compared to an average of multiple FMD tests.  Additionally, due to the technique’s 
application in tracking changes in pre-post interventions, it is important to understand the 
accuracy of repeating measurements on separate days, and what percentage of changes is due to 
measurement error compared to a physiological adaptation. 
Studies in the brachial (Welsch et al., 2002; Peretz et al., 2007; Magda et al., 2012) and 
radial arteries (Brook et al., 2005) have found conflicting results concerning the reliability of the 
FMD test.  Some studies have found that the FMD technique is a stable and reproducible marker 
of vascular function in the brachial artery (Welsch et al., 2002).  Alternatively, other studies have 
shown that brachial FMD may only be satisfactory (Magda et al., 2012), or in the case of the 
radial artery, a very poor (Brook et al., 2005) indicator of vascular function due to high 
variability between repeated measures.  We are unaware of any studies detailing acceptable 
values for day-to-day variability and test-to-test repeatability within the ultrasound measure of 
FMD of the popliteal artery.  Due to the increasing use of this noninvasive technique in clinical 
settings as a prediction of CVD risk, and in physiological research as an assessment of 
endothelial function, there is a strong need for stability of this measure.  The present study aims 
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to examine the test-retest reliability (variability between repeated trials within a day) and 
stability reliability (day-to-day variability in measurements) of the FMD measurement in the 
popliteal artery. 
Between-laboratory comparisons of the magnitude of FMD are often made difficult due 
to the use of different experimental protocols that may affect the physiological response.  The 
use of different occlusion pressures is a major aspect of FMD protocol that is inconsistent 
between laboratories, and the effect on the physiological response of the endothelium is unclear.  
Theoretically any pressure above resting systolic pressure (suprasystolic) should be sufficient to 
occlude blood flow however little research has been done to look at the effects of different 
pressures used on the FMD response.  The present study will permit insight regarding the effect 
of different occlusion pressures on the FMD response.  
Overall, the main objectives of the study were 1) to assess the test-to-test and day-to-day 
reliability of flow-mediated dilation in the popliteal artery; and 2) to examine the effects of five 
different occlusion pressures on the flow-mediated dilation response in the popliteal artery.  We 
hypothesized that 1) there will be good test-retest and stability reliability of flow-mediated 
dilation between tests repeated within the same day and on separate days; and 2) there will be no 
difference in flow-mediated dilation with the five different occlusion pressures. 
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Fig. 1.1 Schematic representation of the pathways involved in flow-mediated dilation (FMD) 
from the initial fluid shear stress stimulus to the resultant change in vessel diameter.  
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Reliability of flow-mediated dilation measures in the popliteal artery and 
implications for use in clinical and research practices   
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2.1 INTRODUCTION 
Flow-mediated dilation (FMD) describes the vasodilation of a conduit artery following an 
increase in shear stress.  This is typically induced by a five minute period of ischemia generated 
by an inflated cuff placed distal to the artery of interest (Corretti et al., 2002).  The FMD 
response is largely nitric oxide (NO)-mediated (Joannides et al., 1995; Mullen et al., 2001) and 
provides information about the integrity of the endothelium (Vita & Keaney, 2002).  Studies 
have shown that impaired endothelial vasodilation is an important feature of vascular disease and 
is strongly associated with several chronic cardiovascular conditions (Neunteufl et al., 2000; 
Perticone et al., 2001; Kuvin et al., 2001; Gokce et al., 2002; Modena et al., 2002; Widlansky et 
al., 2003).  The reactive hyperemia endothelial function test, commonly referred to as an FMD 
test, is presently a widely used, noninvasive technique to provide insight into peripheral conduit 
artery vasoreactivity. 
The FMD technique has increasingly been applied in both clinical and physiological 
studies to examine the mechanisms that impact endothelial and vascular function.  FMD is 
typically assessed in the peripheral conduit arteries, such as the brachial, radial and superficial 
femoral.  More recently, the popliteal artery has emerged as an alternative location for assessing 
endothelial function in the lower limbs.  The magnitude of FMD in the conduit arteries is a 
widely used test of endothelial function.  The FMD test has been documented to correlate with 
invasively assessed endothelial function in the coronary arteries (Anderson et al., 1995), and is 
now commonly used as an index of endothelial function and a surrogate marker of 
cardiovascular disease (CVD).  As a diagnostic tool, it is important to understand the test-retest 
reliability, or the ability to reproduce similar results from consecutive tests within a single day, to 
determine if one FMD test is adequate to represent vasoreactivity of the artery.  Additionally it is 
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important to understand the accuracy of repeating measurements on separate days, and what 
percentage of changes is due to measurement error instead of physiological adaptation. 
Studies in the brachial (Welsch et al., 2002; Peretz et al., 2007; Magda et al., 2012) and 
radial arteries (Brook et al., 2005) have found conflicting results concerning the reliability of the 
FMD test.  Some studies have found that the FMD technique is a stable and reproducible marker 
of vascular function (Welsch et al., 2002).  Alternatively, other studies have shown that FMD 
may only be satisfactory (Magda et al., 2012), or a very poor (Brook et al., 2005) indicator of 
vascular function due to high variability between repeated measures.  We are unaware of any 
studies detailing acceptable values for day-to-day variability and test-to-test repeatability within 
the ultrasound measure of FMD in the popliteal artery.  With the increasing use of this 
noninvasive technique in clinical settings to predict risk of CVD, and in physiological research 
as an assessment of endothelial function, there is a strong need for stability of this measure.  The 
present study aims to examine the test-retest reliability (variability between repeated tests within 
a single day) and stability reliability (day-to-day variability in measurements) of the FMD 
measurement in the popliteal artery. 
Additionally, between-laboratory comparisons of the magnitude of FMD are often 
difficult to make because of different experimental protocols which may affect the physiological 
response.  The use of different occlusion pressures is a major aspect of FMD protocol that 
remains inconsistent between laboratories, and the effect on the physiological response is 
unclear.  Theoretically any occlusion pressure above resting systolic pressure (suprasystolic) 
should be sufficient to occlude blood flow however little research has been done to look at the 
effects of different pressures used on the FMD response.  The present study will permit insight 
regarding the effect of different occlusion pressures on the FMD response.  
13 
 
Overall, the main objectives of the study were 1) to investigate the day-to-day and test-to-
test reliability of flow-mediated dilation in the popliteal artery; and 2) to examine the effects of 
five different occlusion pressures on flow-mediated dilation responses in the popliteal artery.  
We hypothesized that 1) there will be good test-retest and stability reliability of FMD between 
tests repeated within the same day and on separate days; and 2) there will be no difference in 
FMD with the five different occlusion pressures. 
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2.2 METHODS 
2.2.1 Participants 
Ten healthy young men (27 ± 6 yr; mean ± SD; Table 2.1) volunteered and gave written 
consent to participate in the study.  All procedures were approved by The University of Western 
Ontario Research Ethics Board for Health Sciences Research Involving Human Subjects.  All 
participants were recreationally active (regularly exercising to maintain fitness) and non-
smokers.  Additionally, all subjects were normotensive and no subjects were taking medications 
that would affect hemodynamic responses. 
2.2.2 Study Design 
A series of FMD tests were performed on each participant over five consecutive days 
(Figure 2.1).  Tests were performed at the same time each day to minimize diurnal effects.  Two 
FMD tests were performed on each of four days, with a fifth day involving three FMD tests.  
Each FMD test was separated by a 30 minute rest period to allow blood flow and arterial dilation 
to return to resting conditions (Harris et al., 2006).  The first FMD test of each day was 
performed with a different occlusion pressure found throughout the literature: 175; 200; 225; 
250; and 300 mmHg.  The succession of the first FMD test occlusion pressure was randomized 
between subjects, such that one subject may have an occlusion pressure of 175 mmHg for their 
first test on day 1, while another subject may have an occlusion pressure of 250 mmHg.  The 
second FMD test of each day was performed with an occlusion pressure of 250 mmHg, resulting 
in five tests performed in five consecutive days at the same pressure – allowing analysis 
regarding day-to-day variation.  On the day when two FMD tests were performed with an 
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occlusion pressure of 250 mmHg, a third test at that pressure was performed allowing 
determination of the test-retest reliability for three tests within the same day. 
2.2.3 Protocol   
FMD of the popliteal artery was assessed in accordance with previously published 
guidelines for the current standardized methodology (Corretti et al., 2002; Thijssen et al., 
2011a).  All participants were instructed to refrain from caffeine, alcohol and exercise for 12 
hours prior to their scheduled appointments.  Following at least 10 minutes of supine rest, 
participants were instructed to lie prone and a small pillow was placed under their ankle.  The 
left popliteal artery was measured immediately proximal to the bifurcation (usually at or slightly 
above the popliteal fossa), and a pneumatic cuff (Flexiport; Welch Allyn Inc., Skaneateles Falls, 
NY, USA) was placed around the calf (approximately 2-3 inches distal to the popliteal fossa).  
Heart rate was continuously monitored with a three-lead ECG to allow for consistent and 
accurate selection of arterial diameter measurements during the cardiac cycle. 
The popliteal artery was imaged with a 10-MHz multifrequency linear-array transducer 
attached to a Doppler ultrasound machine (VingMed System FiVe, GE Medical Systems, 
Horten, Norway).  All scans were performed by an experienced investigator with training 
obtained through pilot studies, other research projects and comparisons to a phantom artery to 
insure accurate assessment of arterial diameters.  All scans were made under similar conditions 
and all images were recorded on an external video camera (HDD Everio; JVC, Canada) for later 
offline analysis.  Baseline diameter was recorded prior to manual inflation of the pneumatic cuff.  
The cuff was then inflated to the predetermined occlusion pressure, according to which test in the 
series was being performed.  The cuff was inflated for 5 minutes during which diameter was not 
recorded.  15 seconds prior to release of the cuff the video camera started recording.  At exactly 
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5 minutes the pneumatic cuff was released and arterial diameter was continuously monitored for 
5 minutes post-release (Figure 2.2). 
2.2.4 Popliteal Artery Diameter Analysis 
All videos were uploaded and then analyzed using a software program (VirtualDub 
1.6.19.0 by Avery Lee) which allows for frame by frame analysis to ensure that diameter 
measurements were always taken at end diastole (determined by ECG gating).  Triplicate 
measurements of diameter were taken for each of five baseline images and averaged to determine 
the baseline diameter of the artery.  Similarly, triplicate measurements of diameter were 
averaged for a single image taken every 15 seconds following cuff release.  Diameter 
measurements were defined as the distance between the media and intima interface of the near 
wall and far wall (see Figure 2.3).  Peak diameter was determined as the post-occlusion image 
with the largest diameter and FMD was then calculated as the percent change in diameter from 
resting baseline.  Delta was calculated as the difference between peak and baseline diameters 
[Delta (mm) = Peak diameter – Baseline diameter]. 
2.2.5 Statistical Analysis 
 All statistical analyses were performed using SPSS software, version 19 (SPSS Inc., 
Chicago, Ill., USA) and Microsoft Excel 2010 (Microsoft, Seattle, Wash., USA). 
Group mean, standard deviation (SD) and coefficient of variation (SD/mean) were 
calculated for four variables (%FMD, Baseline diameter, Peak diameter and Delta) for each test.  
A one-way repeated measures analysis of variance (ANOVA) was used to determine if there 
were significant differences within the four variables for three comparisons: the FMD tests 
performed at different pressures; the five FMD tests performed over consecutive days; and the 
three FMD tests performed within the same day.  The repeatability of each variable for the three 
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comparisons was calculated by multiplying the within-subject standard deviation (Sw) by 2.77 
[or (1.96 × √2) × Sw] (Bland & Altman, 1996).  The difference between two or more 
measurements for the same subject is less than 2.77 × measurement error for 95% of 
observations (Bland & Altman, 1996).  P < 0.05 was considered significant.  Reliability of three 
FMD tests repeated in a single day and the five tests performed over consecutive days were 
assessed using the intraclass correlation coefficient (ICC (1,1)), which was based on the repeated 
measures ANOVA with testing session as the independent variable (Shrout & Fleiss, 1979). 
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Figure 2.1 Study design outlining the series of FMD tests.  The succession of the occlusion 
pressure for test one was randomized between subjects. 
 
 
 
 
 
Figure 2.2 Schematic representation of the timeline for the FMD test. 
 
  
19 
 
 
 
 
Figure 2.3 Example calculation of baseline diameter (A) and peak diameter and FMD (B) for a 
representative subject. 
  
Baseline Image 
Triplicate measurements 
6.41 mm 
6.41 mm 
6.39 mm 
  
Peak Image 
Triplicate measurements: 
6.77 mm 
6.77 mm 
6.77 mm  
% dilation (FMD) 
= Peak – Baseline diameter  x 100 
           Baseline diameter 
= 6.77 – 6.40 x 100 
        6.40 
= 5.8 % dilation  
 
Averaged   
= 6.77 mm 
A 
B 
Averaged       
= 6.40 mm 
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2.3 RESULTS 
2.3.1 Subject Characteristics 
Subject characteristics are listed in Table 2.1.  
2.3.2 Test-retest Reliability 
The means, SDs and coefficient of variation for FMD, baseline diameter, peak diameter 
and delta of the three tests performed are listed in Table 2.2.  There was no significant difference 
between the three repeats within a day at 250 mmHg occlusion pressure for any of the four 
variables (p > 0.05).  The repeatability of the three FMD tests is also listed in Table 2.2.  The 
repeatability represents the critical value at which a measurable change is observed in a given 
participant between tests.  The repeatability of FMD was 5.62%, which means that a percent 
change in arterial diameter would have to be greater than 5.62 to be considered a physiological 
adaptation rather than measurement error.  The repeatability of baseline diameter, peak diameter 
and delta were 1.92 mm, 2.33 mm and 0.36 mm respectively.  ICCs (also listed in Table 2.2) for 
FMD, baseline diameter, peak diameter and delta were 0.36, 0.91, 0.86 and 0.11 respectively.  
The high ICCs for baseline and peak diameter indicates that there is a good reliability for those 
measures between tests.  Alternatively the low ICCs for FMD and delta indicates that those 
measures have a very poor reliability over the three tests.  This is also illustrated in Figure 2.4; 
the baseline (B) and peak diameter (C) show more consistent measurements over the three FMD 
tests performed whereas FMD (A) and delta (D) show much more variability between tests.  
2.3.3 Day-to-day reliability 
The means, SDs and coefficient of variation for FMD, baseline diameter, peak diameter 
and delta of the five FMD tests performed on separate days (ie. all at 250 mmHg occlusion 
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pressure) are listed in Table 2.3.  There was no significant difference between the five tests for 
any of the four variables (p > 0.05).  The repeatability of the five tests is also listed in Table 2.3.  
The repeatability of FMD, baseline diameter, peak diameter and delta were 4.82%, 1.00 mm, 
1.32 mm and 0.33 mm respectively.  ICCs (also listed in Table 2.3) for FMD, baseline diameter, 
peak diameter and delta were 0.25, 0.62, 0.52 and 0.11 respectively.  Similar to the trends 
observed with the test-retest reliability, the day-to-day reliability of baseline and peak diameter 
measurements were stronger than that of FMD and delta.  Again this is illustrated in Figure 2.5 
depicting greater variability between subjects with FMD (A) and delta (D) compared to baseline 
(B) and peak (C). 
2.3.4 Different Occlusion Pressures 
The means, SDs and coefficient of variation for FMD, baseline diameter, peak diameter 
and delta of the five FMD tests performed at different occlusion pressures are listed in Table 2.4.  
There was no significant difference between the FMD tests performed at different pressures for 
any of the four variables (p>0.05).  The repeatability of the five FMD tests for each of the 
variables is also listed in Table 2.4.  The repeatability of the five FMD tests for FMD, baseline 
diameter, peak diameter and delta were 5.78, 1.16, 1.25 and 0.40 respectively.  Figure 2.6 
illustrates the variability of subjects across the different occlusion pressures.  Similar to the test-
retest and day-to-day reliability, there appears to be less variation with baseline (B) and peak 
diameter (C) measurements compared to FMD (A) and delta (D). 
2.3.5 Time Course of Popliteal FMD 
Pooling all the popliteal FMD tests together (a total of 110 tests), we were able to 
describe the time course of the average FMD response of the popliteal artery over 15 second 
intervals (shown in Figure 2.7).  Time to peak FMD (6.8%) was 180 seconds post cuff release. 
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Table 2.1 Subject Characteristics (n=10) 
  
  
Age (yrs) Mass (kg) Height (cm) 
Resting Blood Pressure 
(mmHg) 
Systolic Diastolic 
Mean 27 81 179 120 65 
SD 6 8 7 7 7 
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Table 2.2 Test-retest reliability statistics for flow-mediated dilation 
properties. 
    Within Day Test 
FMD (%) Test 1 Test 2 Test 3 
Mean 4.5 3.1 5.6 
SD 2.5 2.0 3.5 
Coefficient of Variation 0.55 0.64 0.62 
Between Measurement (p value) - 0.08 - 
Observed Power - 0.45 - 
Repeatability - 5.62 - 
Intraclass Correlation Coefficient - 0.36 - 
Baseline diameter (mm) Test 1 Test 2 Test 3 
Mean 6.5 6.7 6.6 
SD 0.7 0.7 0.8 
Coefficient of Variation 0.11 0.11 0.12 
Between Measurement (p value) - 0.46 - 
Observed Power - 0.16 - 
Repeatability - 1.92 - 
Intraclass Correlation Coefficient - 0.91 - 
Peak diameter (mm) Test 1 Test 2 Test 3 
Mean 6.8 6.9 6.9 
SD 0.7 0.6 0.8 
Coefficient of Variation 0.10 0.09 0.11 
Between Measurement (p value) - 0.65 - 
Observed Power - 0.11 - 
Repeatability - 2.33 - 
Intraclass Correlation Coefficient - 0.86 - 
Delta (mm) Test 1 Test 2 Test 3 
Mean 0.3 0.2 0.4 
SD 0.1 0.1 0.2 
Coefficient of Variation 0.48 0.44 0.59 
Between Measurement (p value) - 0.06 - 
Observed Power - 0.49 - 
Repeatability - 0.36 - 
Intraclass Correlation Coefficient - 0.11 - 
     
- Between measurement, Observed Power, Repeatability and Intraclass 
Correlation Coefficient are reliability statistics that apply to all tests. 
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Figure 2.4 Variability of measures between 
three FMD tests performed on the same day 
for 10 subjects.  Group mean for each test is 
represented by the bar graph. 
 
  
A 
B 
D 
C 
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Table 2.3 Day-to-day reliability statistics for flow-mediated dilation properties. 
 
   
Day-to-Day Tests 
FMD (%) Test 1 Test 2 Test 3 Test 4 Test 5 
Mean 3.3 3.5 4.8 4.5 4.5 
SD 2.1 1.6 1.8 2.3 2.0 
Coefficient of Variation 0.64 0.45 0.37 0.52 0.45 
Between Measurement  
(p value) - - 0.28 - - 
Observed Power - - 0.28 - - 
Repeatability - - 4.82 - - 
Intraclass Correlation 
Coefficient - - 0.25 - - 
Baseline diameter (mm) Test 1 Test 2 Test 3 Test 4 Test 5 
Mean 6.7 6.7 6.7 6.5 6.7 
SD 0.7 0.5 0.6 0.5 0.5 
Coefficient of Variation 0.11 0.08 0.09 0.08 0.07 
Between Measurement  
(p value) - - 0.79 - - 
Observed Power - - 0.10 - - 
Repeatability - - 1.00 - - 
Intraclass Correlation 
Coefficient - - 0.62 - - 
Peak diameter (mm) Test 1 Test 2 Test 3 Test 4 Test 5 
Mean 6.9 6.9 7.0 6.8 7.0 
SD 0.6 0.6 0.6 0.5 0.4 
Coefficient of Variation 0.09 0.08 0.08 0.08 0.06 
Between Measurement  
(p value) - - 0.73 - - 
Observed Power - - 0.11 - - 
Repeatability - - 1.32 - - 
Intraclass Correlation 
Coefficient - - 0.52 - - 
Delta (mm) Test 1 Test 2 Test 3 Test 4 Test 5 
Mean 0.2 0.2 0.3 0.3 0.3 
SD 0.1 0.1 0.1 0.2 0.1 
Coefficient of Variation 0.44 0.52 0.22 0.62 0.42 
Between Measurement  
(p value) - - 0.28 - - 
Observed Power - - 0.25 - - 
Repeatability - - 0.33 - - 
Intraclass Correlation 
Coefficient - - 0.11 - - 
  
  
 
  
- Between measurement, Observed Power, Repeatability and Intraclass Correlation Coefficient are reliability 
statistics that apply to all tests   
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Figure 2.5 Day-to-day variability of 
measures between five FMD tests 
performed on separate days for 10 
subjects.  Group mean for each test is 
represented by the bar graph.  
A 
D 
C 
B 
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Table 2.4 Statistics for flow-mediated dilation properties associated with five different occlusion 
pressures. 
    Occlusion Pressure 
Percent Dilation 175 mmHg 200 mmHg 225 mmHg 250 mmHg 300 mmHg 
Mean 5.5 4.5 3.9 4.5 5.1 
SD 3.2 2.5 1.1 2.5 2.3 
Coefficient of Variation 0.57 0.55 0.28 0.55 0.45 
Between Measurement (p value) - - 0.47 - - 
Observed Power - - 0.22 - - 
Repeatability - - 5.78 - - 
Baseline 175 mmHg 200 mmHg 225 mmHg 250 mmHg 300 mmHg 
Mean 6.6 6.5 6.5 6.5 6.6 
SD 0.8 0.6 0.4 0.7 0.5 
Coefficient of Variation 0.12 0.09 0.07 0.11 0.08 
Between Measurement (p value) - - 0.99 - - 
Observed Power - - 0.05 - - 
Repeatability - - 1.16 - - 
Peak  175 mmHg 200 mmHg 225 mmHg 250 mmHg 300 mmHg 
Mean 6.9 6.8 6.8 6.8 6.9 
SD 0.8 0.6 0.5 0.7 0.5 
Coefficient of Variation 0.12 0.09 0.07 0.10 0.07 
Between Measurement (p value) - - 0.85 - - 
Observed Power - - 0.09 - - 
Repeatability - - 1.25 - - 
Delta 175 mmHg 200 mmHg 225 mmHg 250 mmHg 300 mmHg 
Mean 0.4 0.3 0.3 0.3 0.3 
SD 0.2 0.2 0.1 0.1 0.1 
Coefficient of Variation 0.63 0.54 0.28 0.48 0.42 
Between Measurement (p value) - - 0.41 - - 
Observed Power - - 0.24 - - 
Repeatability - - 0.40 - - 
  
    
 
- Between measurement, Observed Power and Repeatability are reliability statistics that apply to all 
tests. 
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Figure 2.6 Variability of measures 
between five FMD tests performed at 
different occlusion pressures for 10 
subjects.  Group mean for each test is 
represented by the bar graph. 
  
A 
B 
C 
D 
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Figure. 2.7 Time course of popliteal artery dilation following reactive hyperemia.  Time course 
in 15-second intervals of popliteal artery FMD expressed as percent difference from baseline 
after distal cuff occlusion.  Each point on the graph represents an average of all the data available 
at that time-point. 
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2.4 DISCUSSION 
The main goals of this study were to investigate the test-to-test (intraday) and day-to-day 
(interday) reliability of FMD in the popliteal artery, and to examine the effects of five different 
occlusion pressures on the dilatory response in the popliteal artery.  The main findings were as 
follows: 1) repeatability values for these tests were large indicating a high systematic error of the 
technique; 2) reliability of FMD tests was poor both within and between testing days (low ICCs); 
3) there was no significant difference between FMD tests performed in the same day, across five 
days or tests performed at five different occlusion pressures. 
Repeatability is used to examine the influence of measurement errors on data analysis 
and is an indicator of absolute reliability, such that the difference between repeated 
measurements for the same subject is expected to be less than 2.77 × within subject SD (Sw) for 
95% of observations [where 2.77 is derived as (1.96 × √2)] (Bland & Altman, 1996).  In the 
present study, large values of repeatability indicated poor reliability of the technique.  
Repeatability values were high for intra- and interday FMD, such that a difference of 5.62% and 
4.82% respectively would be needed to observe a change in FMD that would not be associated 
with systemic error.  These values for repeatability are as large as the mean FMD measures 
themselves.  This is particularly important for pre- versus post-intervention study designs that 
use FMD tests as an indicator of endothelial function.  With high values of repeatability, the 
likelihood of detecting a difference is small.  The repeatability between days was no worse than 
the within day measures, suggesting it is measurement error rather than variability in day-to-day 
physiological responses.  Studies in the brachial and radial arteries have also shown poor 
reliability as estimated by repeatability.  Hardie et al. (Hardie et al., 1997) demonstrated that 
reproducibility of brachial artery FMD was poor and likely to provide inaccurate measurements 
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for two FMD tests separated by an average of 90 days.  Repeatability calculated from reported 
values for Sw indicated FMD in the brachial artery would need to be approximately 19% to be 
able to detect changes that could not be attributed to systemic error.  This study however, did not 
use the “present-day” standardized technique, consider age or sex differences in participants and 
did not control for diurnal variation, recent exercise or caffeine intake.  More recently, Brook et 
al. (Brook et al., 2005) assessed intra- and interday reliability for two FMD tests performed in 
the same day and two tests performed approximately 7 days apart.  The repeatability calculated 
from reported values for Sw were high for both intraday (10.75%) and interday (10.72%).  The 
authors concluded that radial artery FMD was highly variable.  Although this group did control 
for diurnal variation and dietary intake, they also did not utilize the “present day” standardized 
technique and did not control for sex differences in participants.  Unlike the previous studies, the 
present study utilized the current standardized technique for FMD tests and controlled for 
multiple factors.  
This study also reported ICC, which provides a measure of relative reliability.  Unlike 
measures of absolute reliability, correlation coefficients are influenced by the range of values 
measured and give no indication of actual measurement values or systemic variability within the 
measure itself (Hopkins, 2000).  As suggested by Portney and Watkins (Portney & Watkins, 
2000), ICC values >0.75 are considered to be reliable.  In the present study, ICC values for 
intraday (0.36) and interday (0.25) reliability of FMD indicated very poor reliability of the 
technique.  These ICC values are similar to those reported by Brook et al (Brook et al., 2005) for 
intraday (0.38) and interday (0.23) measures analyzed by the same reader.   Alternatively, 
Welsch et al. (Welsch et al., 2002) reported high reliability of two FMD measures in the brachial 
artery (ICC = 0.92) performed a week apart.  A feature of the present study, is that unlike the 
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previous studies where only two measures were compared, the present study was the first to 
systematically compare five measures for the interday reliability and three measures for intraday 
reliability. 
 Although reliability of FMD was poor for both intra- and interday comparisons, it is 
interesting to note that in both cases the reliability of baseline and peak diameters (which are 
used to calculate the change in diameter and then FMD) were much better than that of delta 
diameter and FMD (expressed as a % change from the baseline value).  The repeatability for 
intraday comparisons was much smaller for baseline (1.92 mm ie. ~30% of the baseline 
diameter) and peak diameter (2.33 mm ie. ~35% of the peak diameter) compared with delta 
diameter (0.36 mm ie. greater than 100% of the delta diameter) and FMD (5.62% ie. greater than 
100% of the FMD).  Additionally, repeatability for interday comparisons was much smaller for 
baseline (1.00 mm i.e. ~ 15% of the baseline value) and peak diameter (1.32 mm, i.e. ~ 20% of 
the peak value) compared to delta diameter (0.33 mm, i.e. greater than 100% of the delta) and 
FMD (4.82% ie. greater than 100% of the FMD).  Similarly, ICC values for intra- and interday 
reliability were much higher for baseline and peak diameter indicating a higher reliability.  In the 
case of intraday reliability, ICC values indicated a good reliability of baseline and peak diameter 
(0.91 and 0.86, respectively).  In agreement with these results,  West et al. (West et al., 2004) 
found baseline diameter to have a small coefficient of variation (CV range of 1-13%), whereas 
the maximal FMD was associated with a much larger variability (CV range 1-84%).  It appears 
that although baseline and peak diameters can be measured with adequate reliability, the delta 
diameter is so small that when adjusted to ratios of % change in diameter or FMD, the error is 
magnified resulting in poor reliability of the measures. 
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 The FMD values reported in the present study are comparable to others in literature 
(Thijssen et al., 2008, 2011b).  Thijssen et al. (Thijssen et al., 2008) reported similar values for 
the popliteal artery of baseline diameter (6.2 ± 1 mm), peak diameter (6.6 ± 1 mm) and FMD 
(6.1 ± 3.3%).  Additionally, the time course of popliteal artery FMD depicted in Figure 2.7 is 
comparable to the time to peak diameter reported by the same group (181 ± 85 seconds) 
(Thijssen et al., 2008).   
 In the present study, there were no significant differences between FMD tests performed 
on the same day or on different days.  Nevertheless it is acknowledged that the study was 
underpowered to detect these differences and thus there is the possibility of a type II error 
(stating that there are no differences when in fact there actually are); in fact, for the three within-
day tests a p-value of 0.08 approaches significance (further demonstrating variability of the 
measure).  Although we acknowledge this is a limitation in the present study, we were interested 
in measuring reliability in this sample size as the majority of research focused studies use small 
sample sizes (often 10 or less subjects) to test physiological adaptations to various exercise 
protocols, or to examine differences between sexes and clinical populations (Joannides et al., 
1995; Mullen et al., 2001; Betik et al., 2004; Green et al., 2006, 2010; Parker et al., 2006, 2011; 
Pyke & Tschakovsky, 2007; Black et al., 2009; Pyke et al., 2009; Tinken et al., 2010).  For this 
reason we wanted to determine the reliability of the FMD technique in these smaller sample sizes 
and understand the limitations when applied to these samples.  That being said, using 
computational modelling of day-to-day FMD measures we generated data for an increased 
sample size, maintaining the same variability in the data.  By doubling the sample size (n=20) we 
doubled the statistical power (0.57), approached significance for differences between tests (p = 
0.06), but with very little change in repeatability (4.69%) and ICC (0.201).  When the sample 
34 
 
size was increased to 40, statistical power above 0.8 was achieved and there was a significant 
difference between tests performed on different days (p = 0.002).  Interestingly, repeatability 
remained relatively unchanged (4.63% vs 4.82%) compared to the original sample size of 10.  
Thus, although the present study was not powered to state that there were no statistically 
significant differences in measures within or between days, it is likely that the repeatability and 
ICC values (which were the main focus of the study) would not be greatly altered with an 
increased sample size.  The measurement error of the FMD technique with 10 subjects is likely 
to remain consistent in larger samples.   
 Another important aspect of this study was to assess the intraday reliability, to determine 
if a single test was repeatable, and therefore an accurate representation of vasoreactivity in the 
popliteal artery.  By averaging two tests (on each day there was an FMD test at 250 mmHg and 
one at another occlusion pressure), we reduced measurement error (decreased repeatability from 
4.82% to 3.90%) suggesting that multiple measures averaged may provide a more accurate 
assessment of changes in FMD.  Sorensen et al. (Sorensen et al., 1995) noted that the 
repeatability of the measure could be reduced from 5.2% to 2.6% when the number of FMD tests 
is increased from one to four for both pre- and post-measures for a given intervention.  In the 
present data we were able to examine the effect of averaging by comparing the average of the 
three tests within a day and the five tests over five days (at 250 mmHg occlusion pressure).  As 
shown in Figure 2.8, the correlation of the averaged values for FMD was not high (r = 0.641).  
Although significant (p = 0.046) there is not a good reliability and there is considerable scatter 
about the line of identity  Therefore, although averaging tests may reduce the repeatability 
slightly, the reliability of the measure is not greatly improved in this sample.  Further analysis is 
needed to determine the importance of averaging measures of FMD responses.   
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 The standardization of the FMD technique is critical for the comparison of FMD values 
obtained between different clinicians and research centres.  An aspect of the FMD protocol that 
remains variable is the occlusion pressure used for the five minute cuff occlusion period.  As 
hypothesized, there were no significant differences between FMD tests performed at five 
different suprasystolic occlusion pressures.  In that regard, however, a larger sample size is 
needed to definitively conclude that there is no effect of occlusion pressure on FMD response in 
the popliteal artery. 
Shear rate (calculated as blood velocity/vessel diameter) is commonly used as a proxy 
measure of shear stress when viscosity measures cannot be obtained.  The shear stress stimulus 
has been identified as the major contributor to the magnitude of FMD (Pyke & Tschakovsky, 
2007).  In some studies of FMD the shear stress is reported in order to estimate the dilation per 
shear rate (Pyke & Tschakovsky, 2005).  In the present study, although we were confident in our 
vessel diameter measures we were not confident in the blood velocity measures which showed 
large variability.  Therefore, it is plausible that the variability in shear stress may affect 
variability and repeatability of FMD, and understanding this interplay requires further study.   
In addition to limitations mentioned above, the present study did not control for dietary 
intake in the hours leading up to FMD tests.  No blood samples were taken and assessed for 
hematological variables known to influence arterial vasodilation such as; lipids (Vogel et al., 
1996; Steinberg et al., 1997); homocysteine (Tawakol et al., 1997; Chambers et al., 1999); 
fibrinogen (Allen et al., 2000); and blood glucose (Title et al., 2000).  Although dietary intake 
should not account for the poor reliability of FMD tests within a day, it is possible that some of 
the variability in FMD measures between days could be attributed to changes in hematological 
factors.  Nevertheless, the day-to-day variation was no worse than the within day repeatability.  
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All ultrasound imaging and analysis were performed by the same investigator.  To ensure no 
bias, analysis should have been completed by a blinded observer.  Furthermore, this study was 
completed with manual analysis of all FMD tests.  This restricted the frequency at which images 
could be selected for diameter measurements.  Manually-derived diameter measurements were 
taken every 15 seconds in the present study.  Current edge-detection software programs allow for 
diameter measurements to be obtained as frequently as each cardiac cycle during the time period 
of interest.  This may provide a more representative time course of vasodilation in the artery 
being imaged. 
 In conclusion, this study demonstrated the popliteal artery FMD measure has poor 
reliability for both test-retest and day-to-day reliability.  The lack of reliability using this 
technique suggests that interpretation of individual or group changes should be made with 
caution, particularly when the FMD values are used for clinical diagnosis.  Baseline and peak 
diameter measures have stronger reliability; however the change in diameter is so small that the 
variation in these measures may be magnified when converted to a delta diameter and the FMD 
ratio, ultimately accounting for the poor reliability exhibited in those measures.  Studies 
involving larger sample sizes are required to confirm this.  Even with the ever increasing number 
of studies addressing reliability of the FMD tests, there remains little consensus.  Due to the 
noninvasive nature of this technique it is likely that it will continue to be a popular research and 
diagnostic tool for assessing endothelial function.  As such, known factors affecting vascular 
reactivity should be strictly controlled for and studies should adhere to standardized protocol and 
analysis for this technique. 
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Figure 2.8 Relationship between the average of three FMD tests within a day and the average of 
five FMD tests over different days (all at 250 mmHg occlusion pressure) (r = 0.641*).  *p < 0.05   
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